Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry

Frost, 2019, Diagnosis of pulmonary hypertension, Eur Respir J, 53, 10.1183/13993003.01904-2018 Rich, 1987, Primary pulmonary hypertension. A national prospective study, Ann Intern Med, 107, 216, 10.7326/0003-4819-107-2-216 Zhang, 2011, Survival of Chinese patients with pulmonary arterial hypertension in the modern treatment era, Chest, 140, 301, 10.1378/chest.10-2327 Alves, 2015, Pulmonary arterial hypertension in the southern hemisphere: results from a registry of incident Brazilian cases, Chest, 147, 495, 10.1378/chest.14-1036 Ling, 2012, Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland, Am J Respir Crit Care Med, 186, 790, 10.1164/rccm.201203-0383OC Frost, 2011, The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US contemporary registries, Chest, 139, 128, 10.1378/chest.10-0075 Hoeper, 2013, Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry, Int J Cardiol, 168, 871, 10.1016/j.ijcard.2012.10.026 Hoeper, 2016, Incidence and prevalence of pulmonary arterial hypertension in Germany, Int J Cardiol, 203, 612, 10.1016/j.ijcard.2015.11.001 Rådegran, 2016, Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014, Scand Cardiovasc J, 50, 243, 10.1080/14017431.2016.1185532 Badagliacca, 2020, Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis, J Heart Lung Transplant, 39, 310, 10.1016/j.healun.2019.12.012 Parikh, 2017, Novel approach to classifying patients with pulmonary arterial hypertension using cluster analysis, Pulm Circ, 7, 486, 10.1177/2045893217705891 Launay, 2018, Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis, PLoS One, 13, 10.1371/journal.pone.0197112 Hoeper, 2015, Pulmonary hypertension in patients with chronic fibrosing idiopathic interstitial pneumonias, PLoS One, 10, 10.1371/journal.pone.0141911 Opitz, 2016, Pre-capillary, combined, and post-capillary pulmonary hypertension: a pathophysiological continuum, J Am Coll Cardiol, 68, 368, 10.1016/j.jacc.2016.05.047 Hoeper, 2017, Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model, Eur Respir J, 50, 10.1183/13993003.00740-2017 Trip, 2013, Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses, Eur Respir J, 42, 1575, 10.1183/09031936.00184412 Hoeper, 2016, Diffusion capacity and mortality in patients with pulmonary hypertension due to heart failure with preserved ejection fraction, JACC Heart Fail, 4, 441, 10.1016/j.jchf.2015.12.016 Galiè, 2015, Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension, N Engl J Med, 373, 834, 10.1056/NEJMoa1413687 Kylhammar, 2018, A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension, Eur Heart J, 39, 4175, 10.1093/eurheartj/ehx257 Galiè, 2015, Eur Respir J, 46, 903, 10.1183/13993003.01032-2015 Galiè, 2016, Eur Heart J, 37, 67, 10.1093/eurheartj/ehv317 McLaughlin, 2019, Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: results from the AMBITION trial, J Heart Lung Transplant, 38, 1286, 10.1016/j.healun.2019.09.010 Statista. Global no.1 business data platform. Available at: www.statista.com . Reddy, 2018, A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction, Circulation, 138, 861, 10.1161/CIRCULATIONAHA.118.034646 Vachiéry, 2019, Pulmonary hypertension due to left heart disease, Eur Respir J, 53, 10.1183/13993003.01897-2018 Borlaug, 2016, Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction, Eur Heart J, 37, 3293, 10.1093/eurheartj/ehw241 Borlaug, 2010, Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction, Circ Heart Fail, 3, 588, 10.1161/CIRCHEARTFAILURE.109.930701 Seimetz, 2011, Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice, Cell, 147, 293, 10.1016/j.cell.2011.08.035 Olsson, 2017, More on idiopathic pulmonary arterial hypertension with a low diffusing capacity, Eur Respir J, 50, 10.1183/13993003.00354-2017 Hoeper, 2017, Is there a vanishing pulmonary capillary syndrome?, Lancet Respir Med, 5, 676, 10.1016/S2213-2600(17)30291-6 Lewis, 2020, Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension, Eur Respir J, 55, 10.1183/13993003.00041-2020